celecoxib + bupivacaine

**Celecoxib + bupivacaine** is a non-fixed combination of two drugs frequently used together for multimodal analgesia in perioperative and postoperative settings. **Bupivacaine** is a long-acting local anesthetic that blocks voltage-gated sodium channels, inhibiting nerve impulse conduction and producing local or regional anesthesia and analgesia. **Celecoxib** is a selective cyclooxygenase-2 (COX-2) inhibitor nonsteroidal anti-inflammatory drug (NSAID), which reduces the synthesis of prostaglandins involved in pain and inflammation. The combination leverages both central and peripheral mechanisms—bupivacaine providing local anesthesia and celecoxib reducing inflammation and pain sensitivity. There is no widely marketed product that combines only these two drugs in a single formulation; their use together typically refers to separate administration as part of a multimodal pain management protocol. Research and clinical experience suggest the combination can improve postoperative pain control and reduce the need for opioids, but the combination is not risk-free and may increase the risk of adverse effects, including methemoglobinemia and other potential drug interactions[2][3][5][7].

Other names

celecoxib + bupivacaine